US Bancorp
VERA icon

US Bancorp’s Vera Therapeutics VERA Stock Holding History

US Bancorp’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.21K Sell
98
-7
-7% -$261 ﹤0.01% 3709
2026
Q1 		$4.22K Buy
105
+62
+144% +$2.67K ﹤0.01% 3625
2025
Q4 		$2.18K Buy
+43
New +$1.53K ﹤0.01% 3743
2025
Q3 		– Sell
-6
Closed -$141 – 4297
2025
Q2 		$141 Sell
6
-53
-90% -$1.19K ﹤0.01% 4099
2025
Q1 		$1.42K Buy
59
+54
+1,080% +$1.74K ﹤0.01% 3936
2024
Q4 		$211 Buy
+5
New +$221 ﹤0.01% 4081
2022
Q2 		– Sell
-1,000
Closed -$23K – 4242
2022
Q1 		$23K Buy
+1,000
New +$21.5K ﹤0.01% 3008

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

US Bancorp's VERA Position: Q2 2026 in Review

US Bancorp reduced its Vera Therapeutics (VERA) stake by 6.7% in Q2 2026, selling an estimated $261 and leaving 98 shares worth $4.21K. The position accounts for ﹤0.01% of the portfolio, ranked #3709.

US Bancorp first reported a position in VERA in Q1 2022 and has held it in 7 quarters since. The position peaked at $23K in Q1 2022. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • US Bancorp held 98 shares of Vera Therapeutics worth $4.21K as of Q2 2026.
  • US Bancorp sold 7 Vera Therapeutics shares in Q2 2026, an estimated $261.
  • Vera Therapeutics made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #3709 holding.
  • US Bancorp first reported a position in Vera Therapeutics in Q1 2022 and has held it in 7 quarters since.
  • US Bancorp's Vera Therapeutics position peaked at $23K in Q1 2022.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.